Jeffrey Solheim is the founder and president of Solheim Enterprises, a company that provides educational and consulting services in emergency department management. He is also the founder and emeritus executive director of Project Helping Hands, an organization that provide humanitarian medical assistance in developing nations. He was the president of the Emergency Nurses Association in 2018. 

Jacopo Tagliabue has graduated in medicine and specialized in geriatrics at the University of Milan, Italy. He is the health director of Paxme Group: Paxme Group is specialized in Home Care and Palliative Home Care in Regione Lombardia, Italy. 

Jeffrey Solheim is the founder and president of Solheim Enterprises, a company that provides educational and consulting services in emergency department management. He is also the founder and emeritus executive director of Project Helping Hands, an organization that provide humanitarian medical assistance in developing nations. He was the president of the Emergency Nurses Association in 2018. 

Susan Jane Kitching is currently undertaking her Professional Doctorate in Nursing Leadership and Motivation. She has over 35 year’s healthcare experience and has held a variety of roles in different organizations within UK and Saudi Arabia. She is currently a Director of Nursing and Quality. She is involved in mentorship of aspiring future leaders and is a member of an editorial board for a Pediatric Journal. 

Raffaele Pilla is the Doctor Europaeus, received his Master’s degree in Pharmacy at G. d’Annunzio University in Chieti-Pescara, Italy in 2005, where he also served internships at the Cell Physiology Laboratory and Molecular Biology Laboratory. He was hired as a postdoctoral scholar in the Department of Pharmacology and Physiology at the University of South Florida in Tampa, on two research grants funded by the Office of Naval Research (US Navy) and Divers’ Alert Network. He has written and lectured widely worldwide. He has been involved in ongoing research at the University of South Florida with the use of ketone esters. 

Masahiro Onuma has expertise in oxidative disease prevention to use non-medical product based on GSK’s experience of allopurinol which is the strongest anti-oxidant efficacy in this world. He creates new indication of allopurinol for stomatitis induced by cancer treatment which was approved by the Japanese Cancer treatment committee to propose new mechanism of allopurinol for anti-oxidant. And now, there are so many new research papers of allopurinol in the world.  

Gerald C Hsu received an honorable PhD in mathematics and majored in engineering at MIT. He attended different universities over 17 years and studied seven academic disciplines. He has spent 20,000 hours in T2D research. First, he studied six metabolic diseases and food nutrition during 2010-2013,then conducted research during 2014-2018. His approach is “math-physics and quantitative medicine” based on mathematics, physics, engineering modeling, signal processing, computer science, big data analytics, statistics, machine learning, and AI. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have. 

Aastha Kalra is board certified in Internal Medicine. She completed her residency in Internal Medicine at Hofstra University- North Shore LIJ Health System in New York and thereafter served as chief resident in Internal Medicine for a year. An outstanding physician, Dr. Kalra’s skills extend beyond traditional medicine to include a special interest in obesity. She is founder physician of telemedicine startup, Weight Zero MD which is a virtual clinic leveraging technology focusing on reversal of metabolic syndrome. 

John F Burd is the founder & CEO of Lysulin Inc, developing scientifically proven nutraceutical products to improve the health of people with diabetes. He is also the co-founder of Sabur Technology Inc., developing a new non-invasive continuous glucose monitoring technology. He is the former president and CEO of DexCom, where he directed the company’s work to develop, manufacture and market the first long-term implantable glucose sensor for people with diabetes. 

Marcos Roberto Tovani Palone has completed his MSc from the Hospital for Rehabilitation of Craniofacial Anomalies, University of Sao Paulo, Brazil, and currently he studies PhD in Experimental Pathology from Ribeirao Preto Medical School, University of Sao Paulo, Brazil, under the coordination of Doctor Leandra Náira Zambelli Ramalho. He is a DDS and, moreover, specialist in pediatric dentistry, syndromes and craniofacial anomalies, and health management.  His main research interests are pediatric pathology, cleft lip and palate, dentistry and public health. He has published more than 50 papers in reputed journals and has been serving as an editorial board member of 30 journals. 

Radia Boufermes has completed her PhD at the age of 45 years from Houari Boumedienne University of Science and Technology (USTHB) in Algiers (Aleria), with the collaboration of National Institute for Agronomic Research (INRA) University of Caen Normandy in France. She is the teacher researcher since 2000 at Badji Mokhtar University of Annaba (Algeria). She has published two research papers in reputed journal.